Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - methylene bis-benzotriazolyl tetramethylbutylphenol, quantity: 40 mg/g; butyl methoxydibenzoylmethane, quantity: 30 mg/g; titanium dioxide, quantity: 26.1 mg/g; bemotrizinol, quantity: 20 mg/g; octocrylene, quantity: 90 mg/g - cream - excipient ingredients: colloidal anhydrous silica; stearyl alcohol; sorbic acid; glyceryl behenate; alkyl (c12-15) benzoate; caprylyl glycol; delta-tocopherol; tribehenin; disodium edetate; tocopheryl glucoside; decyl glucoside; diisopropyl adipate; cyclomethicone; pvp/eicosene copolymer; glycerol; potassium cetyl phosphate; dicaprylyl ether; xanthan gum; propylene glycol; potable water; cetearyl isononanoate; dimeticone 350; caprylic/capric/stearic triglyceride; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Uus-Meremaa - inglise - Ministry for Primary Industries

dermcare-vet (nz) pty ltd - poly(hexamethylene biguanide) hydrochloride; disodium edetate dihydrate - poly(hexamethylene biguanide) hydrochloride 2 g/litre; disodium edetate dihydrate 1.2 g/litre - antimicrobial

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

prodibio sas - gentian violet (unii: j4z741d6o5) (gentian violet cation - unii:3gvj31t6yy), malachite green oxalate (unii: gy1h9o33vu) (malachite green - unii:12058m7oro), ethacridine lactate (unii: v5il571c1t) (ethacridine - unii:wix85m1a6r), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) - gentian violet 0.05 mg in 1 ml - the simultaneous use of water treatment products may decrease the effectiveness of spots & velvets salt. do not use with another treatment. dispose od drugs not entirely used up at the respective collecting points disposal advice: after use, vials must be thrown in recyclable glass rubbish

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

prodibio sas - gentian violet (unii: j4z741d6o5) (gentian violet cation - unii:3gvj31t6yy), malachite green oxalate (unii: gy1h9o33vu) (malachite green - unii:12058m7oro), acriflavine hydrochloride (unii: 1s73vw819c) (acriflavine - unii:1t3a50395t), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) - gentian violet 0.5 mg in 1 ml - invertebrates such as snails and shrimps cannot withstand spots & velvets fresh, and must be removed from the aquarium before beginning the treatment. some filiform plants can be damaged by the treatment. the simultaneous use of softened water may decrease the effectiveness of treatment. do not use with another treatment. dispose od drugs not entirely used up at the respective collecting points disposal advice: after use, vials must be thrown in recyclable glass rubbish

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

prodibio sas - acriflavine hydrochloride (unii: 1s73vw819c) (acriflavine - unii:1t3a50395t), methyl orange (unii: 6b4tc34456) (methyl orange - unii:6b4tc34456), ethacridine lactate (unii: v5il571c1t) (ethacridine - unii:wix85m1a6r), methylene blue anhydrous (unii: 8nap7826ub) (methylene blue - unii:t42p99266k) - acriflavine 2.00 mg in 1 ml - invertebrates such as corals, snails, anemones and shrimps cannot withstand bacteria & fungi salt, and must be removed from the aquarium before beginning the treatment. the simultaneous use of water treatment products may decrease the effectiveness of bacteria & fungi salt. do not use with another treatment. dispose old drugs not entirely used up at the respective collecting points disposal advice: after use, vials must be thrown in recyclable glass rubbish

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

prodibio sas - acriflavine hydrochloride (unii: 1s73vw819c) (acriflavine - unii:1t3a50395t), methyl orange (unii: 6b4tc34456) (methyl orange - unii:6b4tc34456), ethacridine lactate (unii: v5il571c1t) (ethacridine - unii:wix85m1a6r), methylene blue anhydrous (unii: 8nap7826ub) (methylene blue - unii:t42p99266k) - acriflavine 2.00 mg in 1 ml - invertebrates such as snails and shrimps cannot withstand bacteria & fungi fresh, and must be removed from the aquarium before beginning the treatment. some filiform plants can be damaged by the treatment. the simultaneous use of water treatment products may decrease the effectiveness of bacteria & fungi fresh. do not use with another treatment. dispose old drugs not entirely used up at the respective collecting points disposal advice: after use, vials must be thrown in recyclable glass rubbish

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

meda pharmaceuticals - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr) - hyoscyamine sulfate 0.12 mg - urelle® is indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk - benefit should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

avkare - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 118 mg - uroav-b capsules are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. uroav-b capsules are contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

method pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 118 mg - uro-mp capsules are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. uro-mp capsules are contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

aquarium muenster pahlsmeier gmbh - cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), ethacridine lactate (unii: v5il571c1t) (ethacridine - unii:wix85m1a6r), methylene blue anhydrous (unii: 8nap7826ub) (methylene blue cation - unii:zmz79891zh), acriflavine hydrochloride (unii: 1s73vw819c) (acriflavine - unii:1t3a50395t) - cupric cation 10 mg in 1 ml - no known contraindications or side effects. should you notice side effects in your ornamental fish, please inform your vet or pharmacist. take unused medical products and unfinished containers of medical products to the designated collection points. date of last revision of package insert 2013-10-30